ROS-responsive supramolecular antimicrobial peptides-based nanoprodrugs for cervical cancer therapy
Open Access
- 26 November 2024
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 247, 114411
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug deliveryActa Biomaterialia, 2023
- Smart Nanoparticle‐Based Platforms for Regulating Tumor Microenvironment and Cancer ImmunotherapyAdvanced Healthcare Materials, 2022
- Apoptosis regulation at the mitochondria membrane levelBiochimica et Biophysica Acta (BBA) - Biomembranes, 2021
- Peptide-based supramolecular hydrogels for local drug deliveryAdvanced Drug Delivery Reviews, 2021
- Dual‐Targeting Polymeric Nanocarriers to Deliver ROS‐Responsive Prodrugs and Combat Multidrug Resistance of Cancer CellsMacromolecular Bioscience, 2021
- Smart materials for drug delivery and cancer therapyView, 2020
- A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut MicrobiotaAdvanced Science, 2019
- Preparation of multilayer films using the negative charge of phenylboronic acid and its response to pH change, fructose, and hydrogen peroxideColloid and Polymer Science, 2018
- ROS‐responsive drug delivery systemsBioengineering & Translational Medicine, 2016
- Apoptosis and oncogenesis: give and take in the BCL-2 familyCurrent Opinion in Genetics & Development, 2011